Document is current
Any future updates will be listed below
-
Authors
Kolypetri, Panayota
da Silva, Patrick
Francisco, Ronaldo S. Jr
Frenkel, Dan
Cecere, Rachael R.
Kiliaan, Pien C. J.
Montini, Federico
Saxena, Shrishti
Clementi, William A.
Liu, Xuejun
Sun, Cheng
Bergmark, Regan W.
Singhal, Tarun
Saraceno, Taylor J.
Zimmermann, Joseph
Gale, Seth A.
Selkoe, Dennis J.
Chitnis, Tanuja
Weiner, Howard L.
-
Funding
Funding for this research was provided by:
Jiangsu Nhwa Pharmaceutical Co., Ltd and IMab Pharmaceuticals
Davis Alzheimer Prevention Program
Ann Romney Center for Neurologic Diseases
National Institutes of Health (NIA R21AG072486)
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 28 April 2026
First Online: 5 June 2026
Competing interests
: X.L. is an employee of IMab Biopharma Co. Ltd.; C.S. is an employee of Jiangsu Nhwa Pharmaceutical Co. Ltd. The other authors declare no competing interests related to this study.
